186 related articles for article (PubMed ID: 29194436)
1. Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons.
Kondori NR; Paul P; Robbins JP; Liu K; Hildyard JCW; Wells DJ; de Belleroche JS
PLoS One; 2017; 12(12):e0188912. PubMed ID: 29194436
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine.
Paul P; Murphy T; Oseni Z; Sivalokanathan S; de Belleroche JS
Neurobiol Aging; 2014 Apr; 35(4):876-85. PubMed ID: 24138986
[TBL] [Abstract][Full Text] [Related]
3. Experimental approaches for elucidating co-agonist regulation of NMDA receptor in motor neurons: Therapeutic implications for amyotrophic lateral sclerosis (ALS).
Paul P; de Belleroche J
J Pharm Biomed Anal; 2015 Dec; 116():2-6. PubMed ID: 25604957
[TBL] [Abstract][Full Text] [Related]
4. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
[TBL] [Abstract][Full Text] [Related]
5. Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS).
Kondori NR; Paul P; Robbins JP; Liu K; Hildyard JCW; Wells DJ; de Belleroche JS
Front Mol Biosci; 2018; 5():8. PubMed ID: 29487852
[TBL] [Abstract][Full Text] [Related]
6. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase.
Mitchell J; Paul P; Chen HJ; Morris A; Payling M; Falchi M; Habgood J; Panoutsou S; Winkler S; Tisato V; Hajitou A; Smith B; Vance C; Shaw C; Mazarakis ND; de Belleroche J
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7556-61. PubMed ID: 20368421
[TBL] [Abstract][Full Text] [Related]
7. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
8. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
[TBL] [Abstract][Full Text] [Related]
10. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
11. Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis.
Caron I; Micotti E; Paladini A; Merlino G; Plebani L; Forloni G; Modo M; Bendotti C
PLoS One; 2015; 10(7):e0132159. PubMed ID: 26132656
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice.
McLeod VM; Chiam MDF; Lau CL; Rupasinghe TW; Boon WC; Turner BJ
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32621747
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
14. Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS.
Zang DW; Lopes EC; Cheema SS
J Neurosci Res; 2005 Mar; 79(5):694-9. PubMed ID: 15668955
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
Martinez JA; Francis GJ; Liu WQ; Pradzinsky N; Fine J; Wilson M; Hanson LR; Frey WH; Zochodne D; Gordon T; Toth C
Neuroscience; 2008 Dec; 157(4):908-25. PubMed ID: 18951954
[TBL] [Abstract][Full Text] [Related]
16. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
17. The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review.
Paul P; de Belleroche J
Amino Acids; 2012 Nov; 43(5):1823-31. PubMed ID: 22890612
[TBL] [Abstract][Full Text] [Related]
18. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
20. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
